Pneumococcal polysaccharide vaccine solution for injection 0.5ml vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pneumococcal polysaccharide vaccine solution for injection 0.5ml vials

organon pharma (uk) ltd - streptococcus pneumoniae serotype 7f capsular polysaccharide; streptococcus pneumoniae serotype 8 capsular polysaccharide; streptococcus pneumoniae serotype 9n capsular polysaccharide; streptococcus pneumoniae serotype 9v capsular polysaccharide; streptococcus pneumoniae serotype 10a capsular polysaccharide; streptococcus pneumoniae serotype 11a capsular polysaccharide; streptococcus pneumoniae serotype 12f capsular polysaccharide; streptococcus pneumoniae serotype 14 capsular polysaccharide; streptococcus pneumoniae serotype 15b capsular polysaccharide; streptococcus pneumoniae serotype 17a or 17f capsular polysaccharide; streptococcus pneumoniae serotype 18c capsular polysaccharide; streptococcus pneumoniae serotype 19f capsular polysaccharide; streptococcus pneumoniae serotype 19a capsular polysaccharide; streptococcus pneumoniae serotype 20 capsular polysaccharide; streptococcus pneumoniae serotype 22f capsular polysaccharide; streptococcus pneumoniae serotype 23f capsular polysaccharide; streptococcus pneumoniae serotype 33f capsular polysaccharide; streptococcus pneumoniae serotype 1 capsular polysaccharide; streptococcus pneumoniae serotype 2 capsular polysaccharide; streptococcus pneumoniae serotype 3 capsular polysaccharide; streptococcus pneumoniae serotype 4 capsular polysaccharide; streptococcus pneumoniae serotype 5 capsular polysaccharide; streptococcus pneumoniae serotype 6b capsular polysaccharide - solution for injection

Prevenar 13 suspension for injection Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

prevenar 13 suspension for injection

wyeth pharmaceuticals - pneumococcal polysaccharide conjugate vaccine (pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal pol - suspension for injection - 2.2mcg/1 dose+ 2.2mcg/1 dose+ 2.2mcg/1 dose+ 2.2mcg/1 dose+ 2.2mcg/1 dose+ 4.4mcg/1 dose+ 2.2mcg/1 dose+ 2.2mcg/1 dose+ 2.2mcg/1

Pneumococcal polysaccharide vaccine Sanofi Pasteur MSD solution for injection in a vial Malta - English - Medicines Authority

pneumococcal polysaccharide vaccine sanofi pasteur msd solution for injection in a vial

central procurement & supplies unit - pneumococcal polysaccharide, serotype, f conjugated, to crm - solution for injection - pneumococcal polysaccharide serotype 23f conjugated to crm197 25 microgram(s) - vaccines

Pneumococcal Polysaccharide Vaccine Solution for Injection 25mcg/0.5ml Malta - English - Medicines Authority

pneumococcal polysaccharide vaccine solution for injection 25mcg/0.5ml

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - pneumococcal polysaccharide, serotype, conjugated to, crm, b conjugated, to crm, f conjugated, n conjugated, v conjugated, a conjugated, c conjugated - solution for injection - pneumococcal polysaccharide serotype 1 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 2 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 3 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 4 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 5 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 6b conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 7f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 8 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 9n conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 9v conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 10a conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 11a conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 12f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 14 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 15b conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 17f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 18c conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 19f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 19a conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 19f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 20 conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 22f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 23f conjugated to crm197 50 µg/ml pneumococcal polysaccharide serotype 33f conjugated to crm197 50 µg/ml - vaccines

Prevenar 13 suspension for injection Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

prevenar 13 suspension for injection

pfizer manufacturing belgium nv - pneumococcal polysaccharide conjugate vaccine (pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal pol - suspension for injection - 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 4.4mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose

Prevenar 13 suspension for injection Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

prevenar 13 suspension for injection

pfizer manufacturing belgium nv - pneumococcal polysaccharide conjugate vaccine (pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal polysaccharide serotype 19f, pneumococcal polysaccharide serotype 23f) - suspension for injection - 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 4.4mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose

Pneumovax 23 inj. sol. s.c./i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pneumovax 23 inj. sol. s.c./i.m. vial

msd belgium bv-srl - streptococcus pneumoniae type 7f purified capsular polysaccharides ; streptococcus pneumoniae type 9v purified capsular polysaccharides ; streptococcus pneumoniae type 11a purified capsular polysaccharides ; streptococcus pneumoniae type 14 purified capsular polysaccharides ; streptococcus pneumoniae type 18c purified capsular polysaccharides ; streptococcus pneumoniae type 12f purified capsular polysaccharides ; streptococcus pneumoniae type 22f purified capsular polysaccharides ; streptococcus pneumoniae type 10a purified capsular polysaccharides ; streptococcus pneumoniae type 33f purified capsular polysaccharides ; streptococcus pneumoniae type 5 purified capsular polysaccharides ; streptococcus pneumoniae type 23f purified capsular polysaccharides ; streptococcus pneumoniae type 8 purified capsular polysaccharides ; streptococcus pneumoniae type 20 purified capsular polysaccharides ; streptococcus pneumoniae type 4 purified capsular polysaccharides ; streptococcus pneumoniae type 19f purified capsular polysaccharides ; streptococcus pneumoniae type 6b purified capsular polysaccharides ; streptococcus pneumoniae type 17f purified capsular polysaccharides ; streptococcus pneumoniae type 2 purified capsular polysaccharides ; streptococcus pneumoniae type 19a purified capsular polysaccharides ; streptococcus pneumoniae type 9n purified capsular polysaccharides ; streptococcus pneumoniae type 15b purified capsular polysaccharides ; streptococcus pneumoniae type 3 purified capsular polysaccharides ; streptococcus pneumoniae type 1 purified capsular polysaccharides - solution for injection - pneumococcal polysaccharide vaccine, 23-valent - pneumococcus, purified polysaccharides antigen

Pneumo 23 New Zealand - English - Medsafe (Medicines Safety Authority)

pneumo 23

sanofi-aventis new zealand limited - pneumococcal polysaccharide serotype 1 25ug; pneumococcal polysaccharide serotype 10a 25ug; pneumococcal polysaccharide serotype 11a 25ug; pneumococcal polysaccharide serotype 12f 25ug; pneumococcal polysaccharide serotype 14 25ug; pneumococcal polysaccharide serotype 15b 25ug; pneumococcal polysaccharide serotype 17f 25ug; pneumococcal polysaccharide serotype 18c 25ug; pneumococcal polysaccharide serotype 19a 25ug; pneumococcal polysaccharide serotype 19f 25ug; pneumococcal polysaccharide serotype 2 25ug; pneumococcal polysaccharide serotype 20 25ug; pneumococcal polysaccharide serotype 22f 25ug; pneumococcal polysaccharide serotype 23f 25ug; pneumococcal polysaccharide serotype 3 25ug; pneumococcal polysaccharide serotype 33f 25ug; pneumococcal polysaccharide serotype 4 25ug; pneumococcal polysaccharide serotype 5 25ug; pneumococcal polysaccharide serotype 6b 25ug; pneumococcal polysaccharide serotype 7f 25ug; pneumococcal polysaccharide serotype 8 25ug; pneumococcal polysaccharide serotype 9n 25ug; pneumococcal polysaccharide serotype 9v 25ug - suspension for injection - 25 mcg - active: pneumococcal polysaccharide serotype 1 25ug pneumococcal polysaccharide serotype 10a 25ug pneumococcal polysaccharide serotype 11a 25ug pneumococcal polysaccharide serotype 12f 25ug pneumococcal polysaccharide serotype 14 25ug pneumococcal polysaccharide serotype 15b 25ug pneumococcal polysaccharide serotype 17f 25ug pneumococcal polysaccharide serotype 18c 25ug pneumococcal polysaccharide serotype 19a 25ug pneumococcal polysaccharide serotype 19f 25ug pneumococcal polysaccharide serotype 2 25ug pneumococcal polysaccharide serotype 20 25ug pneumococcal polysaccharide serotype 22f 25ug pneumococcal polysaccharide serotype 23f 25ug pneumococcal polysaccharide serotype 3 25ug pneumococcal polysaccharide serotype 33f 25ug pneumococcal polysaccharide serotype 4 25ug pneumococcal polysaccharide serotype 5 25ug pneumococcal polysaccharide serotype 6b 25ug pneumococcal polysaccharide serotype 7f 25ug pneumococcal polysaccharide serotype 8 25ug pneumococcal polysaccharide serotype 9n 25ug pneumococcal polysaccharide serotype 9v 25ug excipient: dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenol sodium chloride water for injection - pneumo 23 is indicated for high risk subjects 2 years of age and above to prevent pneumococcal pneumonia and systemic pneumococcal infections caused by the serotypes included in the vaccine.

SYNFLORIX 4 DOSE Israel - English - Ministry of Health

synflorix 4 dose

glaxo smith kline (israel) ltd - pneumococcal polysaccharide serotype 1; pneumococcal polysaccharide serotype 14; pneumococcal polysaccharide serotype 18c; pneumococcal polysaccharide serotype 19 f; pneumococcal polysaccharide serotype 23f; pneumococcal polysaccharide serotype 4; pneumococcal polysaccharide serotype 5; pneumococcal polysaccharide serotype 6b; pneumococcal polysaccharide serotype 7f; pneumococcal polysaccharide serotype 9v - suspension for injection - pneumococcal polysaccharide serotype 23f 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 18c 3 mcg / 0.5 ml; pneumococcal polysaccharide serotype 14 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 9v 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 7f 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 6b 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 5 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 4 3 mcg / 0.5 ml; pneumococcal polysaccharide serotype 1 1 mcg / 0.5 ml; pneumococcal polysaccharide serotype 19 f 3 mcg / 0.5 ml - pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated - active immunisation against invasive disease, pneumonia and acute otitis media caused by strepococcus pneumoniae serotypes 1, 4,5,6b,7f,9v,14,18c ,19f and 23f in infants and children from 6 weeks up to 5 years of age

PNEUMOVAX 25mcg/0.5m %v/v Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

pneumovax 25mcg/0.5m %v/v solution for injection

sanofi pasteur msd ltd - pneumococcal vaccine - solution for injection - 25mcg/0.5m %v/v - pneumococcal vaccines